The Manufacturing Backbone
Your Pipeline Demands
Nexus CMC is the connective hub between science, manufacturing, regulatory strategy, and external partnerships — purpose-built for early-stage biopharma companies advancing novel small molecules and peptide APIs toward IND, clinical milestones, and licensing conversations.
Your senior CMC advisor is available now — no scheduling, no intake form.
CMC Leadership, Built for the Way
Early-Stage Companies Actually Work
We embed as your senior CMC function — bringing the depth of a fully-staffed department without the overhead of building one.
End-to-End CMC Ownership
From preclinical formulation through clinical supply, process validation, and regulatory filing — we own the manufacturing backbone so your team can focus on science and strategy. One accountable partner across the entire CMC lifecycle.
- Preclinical through Phase III
- Process development & validation
- Scale-up and tech transfer
CDMO & Partner Governance
Rigorous vendor selection, contract negotiation, and ongoing oversight across CDMOs, contract labs, CROs, and 3PLs — anchored in FDA, EMA, ICH, and PIC/S frameworks. We protect your program from the risks that derail timelines.
- RFP, evaluation & selection
- MSA/QAA negotiation
- Ongoing performance oversight
Regulatory-Grounded Strategy
CMC sections for IND, IMPD, NDA/BLA, and CTD submissions across FDA, EMA, MHRA, PMDA, ANVISA, and TGA — built to withstand regulatory scrutiny and support licensing conversations with strategic partners.
- Multi-jurisdictional filings
- Regulatory gap analysis
- Licensing & due diligence packages
Deep Expertise Across Every
Dimension of CMC
A network of functional subject matter experts spanning formulation science, analytical development, regulatory CMC, CDMO management, device integration, and quality systems.
Solid Oral Dosage Forms
IR, MR, and bioavailability enhancement — including amorphous dispersions, particle engineering, and enabling formulation platforms.
Parenteral & Lyophilized Products
Sterile manufacturing strategy, lyophilization cycle development, container-closure selection, and aseptic process design.
Inhalation, Intranasal & Transdermal
Device-integrated formulation strategy, aerosol science, and regulatory pathway navigation for complex delivery routes.
Advanced Delivery Systems
LNPs, nanoparticles, liposomes, and other complex drug delivery platforms — from feasibility through clinical-grade manufacturing.
Peptide API Sourcing & Supply Strategy
Supplier qualification, synthetic route assessment, specification development, and supply chain resilience planning for peptide APIs.
Tech Transfer & Scale-Up
End-to-end technology transfer management — from lab to pilot to commercial scale — with rigorous documentation and risk mitigation.
CDMO Evaluation & Oversight
Structured CDMO selection, audit support, KPI frameworks, and ongoing relationship management anchored in quality and compliance.
Regulatory CMC Filings
Multi-jurisdictional IND, IMPD, NDA/BLA, and CTD CMC sections — authored to meet the expectations of FDA, EMA, MHRA, PMDA, ANVISA, and TGA.
Clinical Supply Chain Management
Clinical packaging, labeling, distribution, and IRT integration — ensuring your clinical supply reaches sites on time and in compliance.
CMC Due Diligence & Investor Packages
Comprehensive CMC data rooms, technical risk assessments, and investor-ready manufacturing packages that support licensing conversations, partnership discussions, and M&A processes. We translate complex CMC into the language of deal-making.
Built for the Companies Where Every CMC Decision Matters Most
We work with companies at the intersection of scientific promise and operational complexity — where the cost of a CMC misstep is measured in months, capital, and deal value.
Discuss Your ProgramEarly-Stage Biopharma
Companies developing novel small molecules and peptide APIs from preclinical through Phase II — where CMC strategy shapes the entire development trajectory.
Dual-Track Strategy Companies
Organizations pursuing parallel licensing/partnership exit and regulatory development tracks — where CMC must simultaneously satisfy technical reviewers and commercial partners.
Lean Teams Needing Senior Depth
Companies that need the judgment and credibility of a seasoned CMC VP without the cost and commitment of a full-time hire — embedded, accountable, and fully integrated.
Pre-IND & Pre-Milestone Companies
Programs approaching IND submission, Phase I readiness, or a licensing conversation that requires a credible, complete CMC story — built to hold up under scrutiny.
Ask Nexus CMC
Engage directly with our senior CMC strategy advisor. Ask about formulation strategy, regulatory pathways, CDMO selection, IND readiness — anything on your CMC agenda. No scheduling required.
Common starting points:
Questions We Hear From
Early-Stage Teams
How does Nexus CMC embed with an early-stage company?
We function as your senior CMC leadership — embedded in your team's workflows, attending your cross-functional meetings, and accountable for CMC outcomes alongside your scientific and business leadership. The engagement model is flexible: fractional CMC leadership, project-specific advisory, or full-spectrum program support from preclinical through NDA. We integrate with your existing team rather than operating as a traditional consulting firm at arm's length.
At what stage should we engage Nexus CMC?
The earlier, the better. CMC decisions made at the preclinical stage — formulation platform selection, API sourcing strategy, CDMO relationships — have compounding effects on cost, timeline, and regulatory risk throughout the entire development program. That said, we regularly engage companies approaching IND, entering Phase I, or preparing for a licensing conversation who need to rapidly build CMC credibility. We meet you where you are.
Can Nexus CMC support multi-jurisdictional regulatory filings?
Yes. We have deep experience authoring CMC sections across FDA, EMA, MHRA, PMDA, ANVISA, and TGA — including IND, IMPD, NDA/BLA, and CTD Module 3. We understand the nuanced differences in what each agency expects and how to structure a CMC package that works across jurisdictions simultaneously, which is critical for companies pursuing global licensing strategies.
We already have a CDMO relationship. Can you help us manage it better?
Absolutely. CDMO governance is one of the highest-leverage activities in early-stage CMC — and one of the most commonly undermanaged. We can audit your existing agreements, establish rigorous oversight frameworks, improve technical communication, and address performance issues before they become program-threatening. We've stepped into many existing CDMO relationships and materially improved outcomes without disrupting the relationship.
What does a CMC due diligence package for licensing look like?
A licensing-ready CMC package typically includes: a comprehensive CMC data room with organized manufacturing history, analytical data, and regulatory correspondence; a technical risk assessment written for a sophisticated acquirer's diligence team; a manufacturing readiness summary; and an executive-level CMC narrative that translates technical complexity into deal language. We've built packages that have withstood scrutiny from major pharma business development teams and their technical advisors.
How quickly can Nexus CMC get up to speed on our program?
We're built for rapid onboarding. Most engagements reach full operational tempo within two to three weeks. Our structured program intake process — reviewing existing CMC documentation, regulatory history, CDMO agreements, and development timelines — lets us identify gaps and priorities quickly. You won't spend months getting a consultant up to speed before they add value. Start a conversation today and we can discuss your specific situation immediately.
Your CMC Function,
Built to Win.
Whether you're approaching IND, entering clinical development, or preparing for a licensing conversation — Nexus CMC provides the senior leadership, regulatory depth, and external partner governance your program needs to succeed.
Start a ConversationYour senior CMC advisor is available right now — no intake form, no waiting.